Who We Are
Bioinformatix designed and developed a patent-pending software program, Rx&You(TM), which is a cloud-based artificial intelligence platform that remotely monitors patient medication behavior in real-time across their whole regimen, and intervenes when appropriate to help solve medication non-adherence, and pharmacovigilance, and coordinates care across many providers to solve polypharmacy. It also creates large volumes of patient-generated data about medication treatment for Big Data analytics to provide major opportunities for maximizing treatment.
In addition, the platform helps pharmaceutical companies satisfy regulations in the US, Europe, and 27 American states that now require electronic reporting of adverse events.
For patients, this means having a reminder system for their whole medication regimen that is patient-centric, (e.g., mobile call vs. email vs. SMS text vs. direct messaging). Our patient-centric reminder system also allows patients to prioritize medications differently thereby improving access to the right type of intervention when they need it most.
For providers, this means illuminating a dark void of information to improve care quality. With Rx&You, quality improves because the provider knows in advance who is not adhering to their regimens on a dose-by-dose basis for every medication, when, and why. The provider literally goes from not knowing who, what, when, or why – to knowing all these things for every patient and medication in near real-time.
Payers benefit because they inure financial savings from cost prevention and containment. By decreasing non-adherence and adverse events, and coordinating care, treatment costs can be prevented from increasing, often by thousands of dollars per patient per year.
Our Team
Executives
Advisors
News
Videos
Our History
The Idea
September 2015The 2 founders had a new idea to improve patient adherence to medications.
First Demo
February 2016The first demo of the RX&You™ platform was given at Massachusetts General Hospital.
First Advisor
March 2016Bioinformatix signed its first advisor from the health insurance sector.
Provisional Patent Filed
April 2016The RX&You™ patents filed at the US Patent & Trademark Office by Fenwick & West.
Top 10 Insurance
July 2016Began due diligence with first Top 10 insurance carrier.
COO named
August 2016Bioinformatix appointed Jeffrey Weiss as its first Chief Operating Officer.
Additional Advisors
August 2016Bioinformatix signs two additional advisors from the pharmaceutical and intellectual property sectors.
First Pharmaceutical Pilot
August 2016RX&You™ Platform pilot invitation from top 10 pharmaceutical company.
First Research Hospital Pilot
September 2016RX&You™ Platform pilot invitation from first medical research hospital.
Astellas C3Prize Finalist
September 2016Bioinformatix was chosen as a top 5 finalist out of 120 entries for its RX&You™ platform.
Found by Press
September 2016Eligible says RX&You™ 1 of 7 healthcare start-ups you should know.
World Tech Finalist
November 2016RX&You™ chosen as 1 of 6 global finalists for WTN Award in health and medicine.
Startup Boot Camp China
May 2017Bioinformatix chosen as the only U.S. digital health company for the inaugural cohort of start-ups.
First Roadshow
September 2017Complete first technology road show in China presenting in 5 major cities.
International Makers Festival
September 2017Guangzhou-Foshan 2017 International Makers Festival picks Rx&You to pitch.
AI+Pharma and Healthcare
October 2017Rx&You™ presents at the 2017 AI+Pharma and Healthcare Innovation Summit.
City of Taizhou
November 2017The city of Taizhou, China selects Rx&You™ to present.
Startup Festival 2017
December 2017Bioinformatix presents on AI in Healthcare at Startup Festival 2017 in Seoul, South Korea.